{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:00:43Z","timestamp":1790600443606,"version":"4.1.0"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Pharmacological Sciences"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.tips.2026.09.002","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:37:16Z","timestamp":1790599036000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting CH25H restores p62-mediated \u03b1-synuclein clearance"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6119-701X","authenticated-orcid":false,"given":"Gavin S.","family":"Dawe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tips.2026.09.002_bb0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson\u2019s disease","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.tips.2026.09.002_bb0010","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41582-024-01034-x","article-title":"Parkinson disease therapy: current strategies and future research priorities","volume":"20","author":"Stocchi","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.tips.2026.09.002_bb0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13024-024-00703-1","article-title":"Brain clearance of protein aggregates: a close-up on astrocytes","volume":"19","author":"Giusti","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tips.2026.09.002_bb0020","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adv7705","article-title":"Targeting of CH25H to boost p62-dependent autophagic degradation of \u03b1-synuclein in cell and mouse models of Parkinson\u2019s disease","volume":"18","author":"Zhang","year":"2026","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tips.2026.09.002_bb0025","article-title":"Therapeutic functions of astrocytes to treat \u03b1-synuclein pathology in Parkinson\u2019s disease","volume":"119","author":"Yang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tips.2026.09.002_bb0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13024-023-00630-7","article-title":"Targeted degradation of \u03b1-synuclein aggregates in Parkinson\u2019s disease using the AUTOTAC technology","volume":"18","author":"Lee","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tips.2026.09.002_bb0035","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20232000","article-title":"Cholesterol 25-hydroxylase mediates neuroinflammation and neurodegeneration in a mouse model of tauopathy","volume":"221","author":"Toral-Rios","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tips.2026.09.002_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2023.100350","article-title":"Regulation of astrocyte lipid metabolism and ApoE secretion by the microglial oxysterol, 25-hydroxycholesterol","volume":"64","author":"Cashikar","year":"2023","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tips.2026.09.002_bb0045","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adm8449","article-title":"Tau fibrils evade autophagy by excessive p62 coating and TAX1BP1 exclusion","volume":"10","author":"Ferrari","year":"2024","journal-title":"Sci. Adv."}],"container-title":["Trends in Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614726002312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165614726002312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T12:37:18Z","timestamp":1790599038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165614726002312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":9,"alternative-id":["S0165614726002312"],"URL":"https:\/\/doi.org\/10.1016\/j.tips.2026.09.002","relation":{},"ISSN":["0165-6147"],"issn-type":[{"value":"0165-6147","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting CH25H restores p62-mediated \u03b1-synuclein clearance","name":"articletitle","label":"Article Title"},{"value":"Trends in Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tips.2026.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}